Evidence map›Paper›PMID 33618607›Full record

ReviewExpert review of anti-infective therapy2021

COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention.

Ashif Iqubal, Mohammad Kashif Iqubal, Farazul Hoda, Abul Kalam Najmi, Syed Ehtaishamul Haque

Open access · greenAbstract readReview
In one paragraph

Review in Expert review of anti-infective therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Observational
  2. Antioxidant Genetic Variants Modify Echocardiography Indices in Long COVID.International journal of molecular sciences · 2023
    Article
  3. Review
  4. Article
  5. Article
  6. Comparison of Fragments in Human Hemostatic Proteins That Mimics Fragments in Proteins of A/H1N1 Viruses and Coronaviruses.Molecular genetics, microbiology and virology : Molekulyarnaya genetika, mikrobiologiya i virusologiya · 2022
    Article
  7. Cardiovascular complications of COVID-19 severe acute respiratory syndrome.American journal of cardiovascular disease · 2022
    Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ashif IqubalDepartment of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
Mohammad Kashif IqubalDepartment of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
Farazul HodaDepartment of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
Abul Kalam NajmiDepartment of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.ORCID 0000-0002-9299-414X
Syed Ehtaishamul HaqueDepartment of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.ORCID 0000-0003-2333-1577
Jamia Hamdard · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Inflammatory AgentsCardiotonic AgentsCardiovascular DiseasesCOVID-19COVID-19 Drug TreatmentCOVID-19 VaccinesHumansAnti-Inflammatory AgentsCardiotonic AgentsCOVID-19 VaccinesCytokine storm; Pneumocytes; Cardiotoxicity; NLRP3 inflammasome and COVID-19

Identifiers

PMID33618607
PMCPMC7938651
OpenAlexW3133037054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.